PENG vs PHPB for Hip Arthroplasty Analgesia
Postoperative Analgesic Effectiveness of Pericapsular Nerve Block (PENG) and Posterior Hip Pericapsular Block (PHPB) in Hip Arthroplasty
1 other identifier
observational
127
1 country
1
Brief Summary
Total hip arthroplasty (THA) is a commonly performed surgical procedure, and its incidence continues to rise with the aging population. Effective postoperative analgesia facilitates early mobilization and accelerates recovery. The pericapsular nerve group (PENG) block provides analgesia to the anterior hip capsule by targeting the articular branches of the femoral, obturator, and accessory obturator nerves. However, due to the contribution of sacral plexus-derived nerves (quadratus femoris, superior gluteal, and inferior gluteal nerves) to posterior hip pain, anterior blocks alone may be insufficient. This prospective study aims to compare the efficacy of preoperatively administered PENG block alone versus the combination of PENG and posterior hip pericapsular block (PHPB) in postoperative pain control after total hip arthroplasty. The primary outcome is postoperative pain intensity assessed by the Numerical Rating Scale (NRS). Secondary outcomes include the Quality of Recovery score (QoR-15), opioid consumption, manual muscle testing (MMT) results, time to mobilization, and block-related complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMay 6, 2026
October 1, 2025
5 months
November 24, 2025
May 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative pain
Postoperative pain will be assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain) at rest and during movement at 0, 2, 6, 8, 12, 24, 36, and 48 hours after surgery. The NRS scores will be compared between the two study groups (PENG vs. PENG + PHPB) to evaluate the effectiveness of the blocks in postoperative analgesia following total hip arthroplasty.
Up to 48 hours postoperatively
Secondary Outcomes (5)
QUALİTY OF RECOVERY-15
Preoperative, 24, and 48 hours postoperatively
MANUEL MUSCLE TEST
6, 12, and 24 hours postoperatively
Rescue analgesic
0-48 hours postoperatively
Postoperative Nausea and Vomiting (PONV)
0-48 hours postoperatively
Length of Hospital Stay
Up to discharge (approximately 3-5 days postoperatively)
Study Arms (2)
PENG Group
The group that will receive the preoperative Pericapsular Nerve Group (PENG) block
PENG + PHPB Group
The group that will receive the preoperative Pericapsular Nerve Group (PENG) block and Posterior Hip Pericapsular Block (PHPB)
Interventions
Patients in this group will also undergo elective total hip arthroplasty (THA) under spinal anesthesia.A preoperative Pericapsular Nerve Group (PENG) block will be performed under ultrasound guidance using 20 mL of 0.25% bupivacaine. The injection will be administered between the psoas tendon and the iliac bone to block the articular branches of the femoral, obturator, and accessory obturator nerves, providing analgesia to the anterior hip capsule. In addition to the PENG block, a Posterior Hip Pericapsular Block (PHPB) will be performed under ultrasound guidance using 20 mL of 0.25% bupivacaine. The local anesthetic will be injected between the piriformis muscle and the ischiofemoral ligament to target the posterior articular branches of the quadratus femoris, superior gluteal, and inferior gluteal nerves. The combined PENG + PHPB approach aims to provide comprehensive analgesia of both the anterior and posterior hip capsule while preserving motor function.
Patients in this group will also undergo elective total hip arthroplasty (THA) under spinal anesthesia.A preoperative Pericapsular Nerve Group (PENG) block will be performed under ultrasound guidance using 20 mL of 0.25% bupivacaine. The injection will be administered between the psoas tendon and the iliac bone to block the articular branches of the femoral, obturator, and accessory obturator nerves, providing analgesia to the anterior hip capsule.
Eligibility Criteria
Adult patients aged 18 years and older, classified as ASA physical status I-II, scheduled for elective total hip arthroplasty under spinal anesthesia at Ankara Bilkent City Hospital. A total of 132 patients who meet the inclusion criteria and provide written informed consent will be enrolled in this single-center, prospective, randomized controlled trial.
You may qualify if:
- Patients scheduled for elective total hip arthroplasty (THA) under spinal anesthesia
- ASA physical status I-II
- Age ≥18 years
- Body Mass Index (BMI) between 18-35 kg/m²
- Patients who provide written informed consent
You may not qualify if:
- Age \<18 years
- ASA physical status ≥III
- Known allergy or contraindication to study medications (local anesthetics, opioids, etc.)
- Severe cardiac, renal, hepatic, or pulmonary failure
- Revision total hip arthroplasty
- Coagulopathy or anticoagulant use
- Local infection or neuropathic findings at the injection site
- Chronic inflammatory diseases or chronic corticosteroid use
- Diagnosed neuropsychiatric disorders
- Pregnancy or lactation
- Inability or unwillingness to read, understand, or sign the informed consent form
- Obesity (BMI \>35 kg/m²)
- Failed spinal anesthesia or conversion to general anesthesia
- Active malignancy or patients receiving radiotherapy/chemotherapy
- Active systemic infection or ongoing antibiotic therapy (except prophylaxis)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital Departmant of Anesthesiology and Reanimation, Ankara,Çankaya
Ankara, Çankaya, 06800, Turkey (Türkiye)
Related Publications (3)
Atalay YO, Ciftci B, Tekin B, Ansen G, Sakul BU, Cacan MA, Azboy I, Yilmaz B, Alici HA. A Case Series of Deep Subgluteal Block: A New Block Targeting the Missed Portion of the Hip for Analgesia After Total Hip Replacement. A A Pract. 2024 Sep 9;18(9):e01848. doi: 10.1213/XAA.0000000000001848. eCollection 2024 Sep 1.
PMID: 39250338RESULTDuan L, Li J, Chen Z, Wen T, He J, Zhang A. Posterior Hip Pericapsular Block (PHPB) with pericapsular nerve group (PENG) block for hip fracture: a case series. BMC Anesthesiol. 2024 Oct 1;24(1):352. doi: 10.1186/s12871-024-02731-2.
PMID: 39354374RESULTVermeylen K, Van Aken D, Versyck B, Casaer S, Bleys R, Bracke P, Groen G. Deep posterior gluteal compartment block for regional anaesthesia of the posterior hip: a proof-of-concept pilot study. BJA Open. 2023 Feb 15;5:100127. doi: 10.1016/j.bjao.2023.100127. eCollection 2023 Mar.
PMID: 37587997RESULT
Study Officials
- STUDY DIRECTOR
Abdulkadir But, Professor
Ankara Bilkent City Hospital Departmant of Anesthesiology and Reanimation,Ankara,Çankaya
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2025
First Posted
December 4, 2025
Study Start
December 1, 2025
Primary Completion
April 15, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 6, 2026
Record last verified: 2025-10